ask="N/A"
ask_size="N/A"
average_daily_volume="391402"
bid="N/A"
bid_size="N/A"
book_value="14.89"
change="-1.29"
change_from_200_day_moving_average="0.28"
change_from_50_day_moving_average="-4.49"
change_from_52_week_high="-11.22"
change_From_52_week_low="21.75"
change_in_percent="-2.53%"
close="49.76"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="8.95"
ebitda="267.62M"
eps_estimate_current_year="-2.27"
eps_estimate_next_quarter="-0.81"
eps_estimate_next_year="-3.17"
ex_dividend_date="N/A"
float_shares="23975000"
high="51.16"
high_52_weeks="60.98"
last_trade_date="1/5/2017"
last_trade_price="49.76"
last_trade_size="29187"
last_trade_time="4:00pm"
low="49.15"
low_52_weeks="28.01"
market_capitalization="1.35B"
moving_average_200_day="49.48"
moving_average_50_day="54.25"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="58.50"
open="50.98"
pe_ratio="5.56"
peg_ratio="0.37"
percent_change_from_200_day_moving_average="+0.58%"
percent_change_from_50_day_moving_average="-8.28%"
percent_change_from_52_week_high="-18.40%"
percent_change_from_52_week_low="+77.65%"
previous_close="51.05"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.43"
price_per_sales="3.59"
revenue="385.77M"
shares_outstanding="27138000"
short_ratio="6.50"
stock_exchange="NMS"
symbol="FPRX"
volume="395425"
weeks_range_52="28.01 - 60.98"
